Delivery Order SPE2DB25D3012-SPE2DB25FWZLS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen injections, with a ceiling value of $7,126.08. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract was completed on August 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- This is a $3,769.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract has an ultimate completion date of August 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 3-Pak 18 mg/3 ml pen 3 ml. The contract has a firm fixed price of $26,498.98 and a completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Victoza 3-Pak 18 mg/3 ml pen, a medication used to treat diabetes. The delivery order contract is valued at $6,404.26 and has a completion date of October 6, 2023. The contract is a firm fixed-price, delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide the Victoza 2-Pak 18 mg/3 ml pen medication. The $1,771.72 award has a performance period through January 13, 2023. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,979.56 award is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of May 1, 2023 and does not include any set-aside designations, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,847.54, is a delivery order for the supply of Victoza 3-Pak 18 mg/3 ml Pen 3 ml, a medication used for the treatment of type 2 diabetes. The contract has an ultimate completion date of November 16, 2023 and is designated as a firm fixed-price contract. No set-aside requirements were used...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,178.22, is for the provision of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of November 16, 2023 and was awarded on November 15, 2023. This delivery order is part of a larger $999,999,999...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,437.62, is a delivery order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a $2,737.08 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Victoza 3-pak 18 mg/3 ml pens. The contract has an ultimate completion date of October 31, 2023. AmerisourceBergen is the prime contractor, and this award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZLSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,187.70 to AmerisourceBergen Drug Corp for the supply of Victoza 3-Pak 18 mg/3 ml pen (3 ml), a diabetes medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and an ultimate completion date of August 25, 2025. The contract was executed on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceuticals and medical supplies to military healthcare programs worldwide. The DLA Troop Support Medical contract represents a strategic procurement vehicle designed to support the Defense Health Agency and other federal healthcare systems with essential medications, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/22/25 |